Dongwha Pharm.Co.,Ltd
Dongwha Pharm.Co.,Ltd (KRX: 000020) is trading at ₩5,360.00, about ₹387 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 4.46% today. Dongwha Pharm.Co. is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩5,340.00
Today's high
₩5,510.00
52 week low
₩4,450.00
52 week high
₩7,560.00
000020 opened at ₩5,500.00, closed previously at ₩5,610.00, and has traded between ₩4,450.00 and ₩7,560.00 over the past 52 weeks.
About
Dongwha Pharm Co., Ltd. is a South Korean entity primarily engaged in the production and distribution of pharmaceutical goods. The company's diverse offerings include prescription-only medications addressing a wide spectrum of health concerns such as digestive and infectious diseases, cardiovascular and metabolic disorders, inflammatory and respiratory conditions, musculoskeletal and neurological ailments, as well as dermatological and urological issues. Furthermore, they market an extensive selection of over-the-counter (OTC) remedies, covering categories like digestive aids, cold and flu treatments, anti-inflammatory and respiratory solutions, skin care, oral hygiene, liver support, nutritional supplements, tonics, topical pain relief, antihistamines, and remedies for sore throats, among other products. Beyond pharmaceuticals, Dongwha Pharm also ventures into quasi-drugs, health supplements, food and beverage items, and cosmetics. Established in 1897, the firm maintains its headquarters in Seoul, South Korea.
Key statistics
Avg. volume
334.49K
Market cap
₩148.57B
P/E Ratio
8.21
Price-to-sales ratio
0.29
Enterprise value
₩279.68B
Free cash flow yield
-21.47%
Debt-to-equity ratio
0.31
Return on equity
2.29%
ROIC
-0.10%
Beta
0.36
Dividend yield
4.57%
Last dividend
₩245.00
Financial overview
Revenue
₩496.39B
Earnings per share
₩313.37
Free cash flow
-₩37.48B
Net profit margin
3.52%
Gross margin
41.84%
EBITDA
₩21.16B
Revenue growth
6.78%
Similar securities
This is not an investment recommendation
Dongwha Pharm.Co. for Indian investors
Dongwha Pharm.Co. is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Dongwha Pharm.Co. for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Dongwha Pharm.Co.’s current yield is 4.57%.Dividend tax explained
FAQs
Can I buy Dongwha Pharm.Co. on Paasa?
Dongwha Pharm.Co. (000020) has been listed on the Korea Exchange since 1976, in the Drug Manufacturers - Specialty & Generic industry. Dongwha Pharm.Co. is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Dongwha Pharm.Co. share cost in rupees?
One Dongwha Pharm.Co. share is ₩5,360.00 — about ₹387 at a KRW/INR rate of 0.0722 on 9 Oct 2026. Both the Dongwha Pharm.Co. price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Dongwha Pharm.Co. shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Dongwha Pharm.Co. price.
Does Dongwha Pharm.Co. pay a dividend, and how is it taxed in India?
Yes. Dongwha Pharm.Co. pays a dividend and the current yield is 4.57%; the last declared dividend was ₩245.00 per share, about ₹17.69. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Dongwha Pharm.Co. shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Dongwha Pharm.Co.?
Yes. Dongwha Pharm.Co. is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.